{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:36:05Z","timestamp":1777250165083,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13067-2","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:47:18Z","timestamp":1773809238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence, survival, and risk factors for first-line antiretroviral therapy failure among adults on ART follow-up in health facilities in Southwest Shoa, Oromia, Ethiopia, 2023: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Setegn","family":"Gemechu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amsalu Mekonnen","family":"Wolde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebuma","family":"Sorsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desalegn Tamiru","family":"Negese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohannes","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"13067_CR1","unstructured":"World Health Organization. Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation, and monitoring. 2021. 67 p."},{"key":"13067_CR2","unstructured":"UNAIDS. Global HIV statistics Fact Sheet 2023. 2023."},{"issue":"01","key":"13067_CR3","first-page":"988","volume":"15","author":"J Landon","year":"2024","unstructured":"Landon J. Advancements in HIV Treatment: The Impact of Antiretroviral Therapy on Patient Health and Quality of Life. J AIDS Clin Res. 2024;15(01):988.","journal-title":"J AIDS Clin Res"},{"key":"13067_CR4","unstructured":"National Institute of Health. Too many people with HIV fail to achieve durable viral suppression [Internet]. 2021 [cited 2023 Feb 22]. Available from: https:\/\/www.nih.gov\/news-events\/news-releases"},{"key":"13067_CR5","unstructured":"UNAIDS. The Urgency of Now: AIDS at a Crossroads. Geneva; 2024. p. 6."},{"key":"13067_CR6","unstructured":"EPHI. HIV Related Estimates and Projections in Ethiopia for the Year 2022\u20132023. Addis Ababa, 2023."},{"key":"13067_CR7","unstructured":"CDC Ethiopia. Strategic focus: CDC Division of Global HIV & TB Country Profiles. Addis Ababa, 2022."},{"issue":"4","key":"13067_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/hiv.12421","volume":"18","author":"S Teeraananchai","year":"2017","unstructured":"Teeraananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med. 2017;18(4):256\u201366.","journal-title":"HIV Med"},{"issue":"10","key":"13067_CR9","doi-asserted-by":"publisher","first-page":"e0275204","DOI":"10.1371\/journal.pone.0275204","volume":"17","author":"DE Andarge","year":"2022","unstructured":"Andarge DE, Ewnetu H, Id H, Menna T. Incidence, survival time, and associated factors of virological failure among adult HIV\/AIDS patients on first-line antiretroviral therapy in St. Paul\u2019s Hospital Millennium Medical College - A retrospective cohort study. PLoS ONE. 2022;17(10):e0275204.","journal-title":"PLoS ONE"},{"key":"13067_CR10","unstructured":"WHO. HIV and AIDS. WHO Regional websites. 2023."},{"key":"13067_CR11","unstructured":"FMoH. National Consolidated Guidelines for Comprehensive HIV Prevention, Care and Treatment. 4th ed. Addis Abeba; 2018. p. 75."},{"key":"13067_CR12","unstructured":"WHO. Antiretroviral therapy for HIV Infection in adults and adolescents: recommendations for a public health approach. WHO guidelines. 2010. 156 p."},{"key":"13067_CR13","unstructured":"World Health Organization. HIV prevention, testing, treatment, service delivery, and monitoring. 2021. 594 p."},{"issue":"7","key":"13067_CR14","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1016\/S2352-3018(15)00087-9","volume":"2","author":"AD Haas","year":"2015","unstructured":"Haas AD, Keiser O, Balestre E, Brown S, Bissagnene E, Chimbetete C, et al. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: Collaborative analysis. Lancet HIV. 2015;2(7):e271\u20138.","journal-title":"Lancet HIV"},{"key":"13067_CR15","doi-asserted-by":"crossref","unstructured":"Demeke Alemu K, Abebe Moges N, Jara Boneya D, Assemu Asrade A, Degu Tsega TSTA. Time to switch to second-line anti-retroviral treatment and its predictors among HIV-infected adults with virological failure in Northwest Ethiopia: a retrospective follow-up study. HIV\/AIDS\u2014Res Palliat Care. 2022;87\u2013100.","DOI":"10.2147\/HIV.S348076"},{"key":"13067_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2050312120906076","volume":"8","author":"R Feleke","year":"2020","unstructured":"Feleke R, Geda B, Teji Roba K, Weldegebreal F. Magnitude of antiretroviral treatment failure and associated factors among adult HIV-positive patients in Harar public hospitals, Eastern Ethiopia. SAGE Open Med. 2020;8:1\u20137.","journal-title":"SAGE Open Med"},{"key":"13067_CR17","doi-asserted-by":"publisher","first-page":"100621","DOI":"10.1016\/j.curtheres.2020.100621","volume":"94","author":"G Dessie","year":"2021","unstructured":"Dessie G, Mulugeta H, Wagnew F, Zegeye A, Kiross D, Negesse A, et al. Immunological Treatment Failure Among Adult Patients Receiving Highly Active Antiretroviral Therapy in East Africa: A Systematic Review and Meta-Analysis. Curr Ther Res - Clin Exp. 2021;94:100621.","journal-title":"Curr Ther Res - Clin Exp"},{"issue":"1","key":"13067_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/hiv.12790","volume":"21","author":"J Birungi","year":"2020","unstructured":"Birungi J, Cui Z, Okoboi S, Kapaata A, Munderi P, Mukajjanga C, et al. Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural Uganda. HIV Med. 2020;21(1):21\u20139.","journal-title":"HIV Med"},{"issue":"32","key":"13067_CR19","first-page":"1","volume":"4","author":"MA Assemie","year":"2019","unstructured":"Assemie MA, Alene M, Ketema DB, Mulatu S. Treatment failure and associated factors among first-line patients on highly active antiretroviral therapy in Ethiopia: a systematic review and meta-analysis. Glob Heal Res Policy. 2019;4(32):1\u201310.","journal-title":"Glob Heal Res Policy"},{"key":"13067_CR20","doi-asserted-by":"crossref","unstructured":"Blanco L, Montaner JSG, Marconi VC, Santoro MM, Campos-Loza AE, Shafer RW, et al. Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with Atripla vs. tenofovir\u2009+\u2009emtricitabine\/lamivudine\u2009+\u2009efavirenz administered on a multiple tablet therapy. 2014;28(17): 2531\u20139.","DOI":"10.1097\/QAD.0000000000000424"},{"issue":"1","key":"13067_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.mjafi.2016.09.008","volume":"73","author":"S Patrikar","year":"2017","unstructured":"Patrikar S, Capt G, Shankar S, Kotwal BA, Basannar DR, Vijay C, et al. ScienceDirect Predictors of first-line antiretroviral therapy failure and burden of second-line antiretroviral therapy. Med J Armed Forces India. 2017;73(1):5\u201311.","journal-title":"Med J Armed Forces India"},{"issue":"10","key":"13067_CR22","doi-asserted-by":"publisher","first-page":"e0164299","DOI":"10.1371\/journal.pone.0164299","volume":"11","author":"D Haile","year":"2016","unstructured":"Haile D, Takele A, Gashaw K, Demelash H, Nigatu D. Predictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, Southeastern Ethiopia. PLoS ONE. 2016;11(10):e0164299.","journal-title":"PLoS ONE"},{"issue":"16","key":"13067_CR23","first-page":"1","volume":"18","author":"A Mesic","year":"2021","unstructured":"Mesic A, Spina A, Mar HT, Thit P, Decroo T, Lenglet A, et al. Predictors of virological failure among people living with HIV receiving first-line antiretroviral treatment in Myanmar: retrospective cohort analysis. AIDS Res Ther. 2021;18(16):1\u201312.","journal-title":"AIDS Res Ther"},{"key":"13067_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-05177-2","volume":"20","author":"CD Agegnehu","year":"2020","unstructured":"Agegnehu CD, Merid MW, Yenit MK. Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals, Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2020;20:1\u201314.","journal-title":"BMC Infect Dis"},{"key":"13067_CR25","doi-asserted-by":"crossref","unstructured":"Agezew T, Tadesse A, Derseh LYM. Incidence and predictors of first-line anti-retroviral therapy failure among adults receiving HIV care in Northwest Ethiopia: J Infect Dis Epidemiol. 2019;5(072):1\u20137.","DOI":"10.23937\/2474-3658\/1510072"},{"key":"13067_CR26","doi-asserted-by":"crossref","unstructured":"Samizi FG, Panga OD, Malugu SS, Gitige CG, Mmbaga EJ. Rates and predictors of HIV virological failure among adults on first-line antiretroviral treatment in Dar Es Salaam, Tanzania. J Infect Dev Ctries. 2021;15(6).","DOI":"10.3855\/jidc.13603"},{"issue":"771","key":"13067_CR27","first-page":"1","volume":"19","author":"GA Lenjiso","year":"2019","unstructured":"Lenjiso GA, Endale BS, Bacha YD. Clinical and immunological failure among HIV-positive adults taking first-line antiretroviral therapy in Dire Dawa, eastern Ethiopia. BMC Public Health. 2019;19(771):1\u201310.","journal-title":"BMC Public Health"},{"issue":"1","key":"13067_CR28","first-page":"1","volume":"8","author":"G Bereda","year":"2021","unstructured":"Bereda G, Bereda G. Prevalence of, and Factors Influencing First-Line Antiretroviral Treatment Failure among Adult HIV Patients at Antiretroviral Treatment Clinic of Mettu Karl Referral Hospital, Southwestern, Ethiopia: A Prospective Cross-Sectional Study, 2021. Int J Virol AIDS. 2021;8(1):1\u20139.","journal-title":"Int J Virol AIDS"},{"issue":"82","key":"13067_CR29","first-page":"1","volume":"20","author":"A Endalamaw","year":"2020","unstructured":"Endalamaw A, Mekonnen M, Geremew D, Yehualashet FA, Tesera H. HIV\/AIDS treatment failure and associated factors in Ethiopia: meta-analysis. BMC Public Health. 2020;20(82):1\u201312.","journal-title":"BMC Public Health"},{"issue":"7","key":"13067_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2019-036223","volume":"10","author":"HM Meshesha","year":"2020","unstructured":"Meshesha HM, Nigussie ZM, Asrat A, Mulatu K. Determinants of virological failure among adults on first-line highly active antiretroviral therapy at public health facilities in Kombolcha town, Northeast, Ethiopia: A case-control study. BMJ Open. 2020;10(7):1\u20139.","journal-title":"BMJ Open"},{"issue":"1","key":"13067_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4314\/ahs.v21i1.34","volume":"21","author":"A Genet","year":"2021","unstructured":"Genet A, Mekonnen Z, Yizengaw E, Mekonnen D, Mekonnen D. First-line antiretroviral treatment failure and associated factors among people living with HIV in northwest Ethiopia. Afr Health Sci. 2021;21(1):263\u201372.","journal-title":"Afr Health Sci"},{"issue":"2","key":"13067_CR32","first-page":"69","volume":"8","author":"HA Mekonnen","year":"2023","unstructured":"Mekonnen HA, Aregaw FM, Yesuf T, Derseh NM. Prevalence of Virologic Failure and Determinants Among Adults on First-Line Antiretroviral Therapy at Debre Tabor Comprehensive Specialized Hospital in Northwest Ethiopia. Int J Infect Dis Ther. 2023;8(2):69\u201379.","journal-title":"Int J Infect Dis Ther"},{"key":"13067_CR33","doi-asserted-by":"publisher","first-page":"916454","DOI":"10.3389\/fpubh.2022.916454","volume":"10","author":"B Bogale","year":"2022","unstructured":"Bogale B, Asefa A, Destaw A, Gachana Midaksa ZA, Gebremichael MA, Asrat Arja Wolde EY. Determinants of virological failure among patients on first-line highly active antiretroviral therapy (HAART) in central Oromia, Ethiopia: A case-control study. Front Public Health. 2022;10:916454.","journal-title":"Front Public Health"},{"issue":"9","key":"13067_CR34","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1016\/S2352-3018(20)30172-7","volume":"7","author":"A Gupta-Wright","year":"2020","unstructured":"Gupta-Wright A, Fielding KL, van Oosterhout JJ, et al. Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study. Lancet HIV. 2020;7(9):e620\u20138.","journal-title":"Lancet HIV"},{"issue":"2","key":"13067_CR35","first-page":"175","volume":"29","author":"BO Enderis","year":"2019","unstructured":"Enderis BO, Hebo SH, Debir MK, Sidamo NB, Shimber MS. Predictors of Time to First-Line Antiretroviral Treatment Failure among Adult Patients Living with HIV in Public Health Facilities of Arba Minch Town, Southern Ethiopia. Ethiop J Health Sci. 2019;29(2):175\u201386.","journal-title":"Ethiop J Health Sci"},{"issue":"12","key":"13067_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4172\/2155-6113.1000749","volume":"8","author":"C Sisay","year":"2017","unstructured":"Sisay C, Bekele A, Sisay A, Mekonin H, Terfa K, et al. Incidence and Predictors of Anti-Retroviral Treatment (ART) Failure among AIDS & Clinical Research Incidence and Predictors of Anti-Retroviral Treatment (ART) Failure among Adults Receiving HIV Care at Zewditu Memorial Hospital, Addis Ababa. J AIDS Clin Res. 2017;8(12):7.","journal-title":"J AIDS Clin Res"},{"issue":"5","key":"13067_CR37","doi-asserted-by":"publisher","first-page":"e0126026","DOI":"10.1371\/journal.pone.0126026","volume":"10","author":"YT Yimer","year":"2015","unstructured":"Yimer YT, Yalew AW. Magnitude and Predictors of Anti-Retroviral Treatment (ART) Failure in Private Health Facilities in Addis Ababa, Ethiopia. PLoS ONE. 2015;10(5):e0126026.","journal-title":"PLoS ONE"},{"key":"13067_CR38","doi-asserted-by":"crossref","unstructured":"Assefa A, Gelaw B, Getnet G, Yitayew G. The effect of incident tuberculosis on the immunological response of HIV patients on highly active antiretroviral therapy at the University of Gondar Hospital, northwest Ethiopia: a retrospective follow-up study. 2014.","DOI":"10.1186\/1471-2334-14-468"},{"issue":"March","key":"13067_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/HIV.S346182","volume":"14","author":"KD Tegegne","year":"2022","unstructured":"Tegegne KD, Cherie N, Tadesse F, Biset G, Tilahun L, Kassaw MW. Incidence and Predictors of Opportunistic Infections Among Adult HIV-Infected Patients on Anti-Retroviral Therapy at Dessie Comprehensive Specialized Hospital, Ethiopia: A Retrospective Follow-Up Study. HIV\/AIDS\u2014Res Palliat Care. 2022;14(March):195\u2013206.","journal-title":"HIV\/AIDS\u2014Res Palliat Care"},{"key":"13067_CR40","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2147\/PPA.S252805","volume":"14","author":"GB Mekonnen","year":"2020","unstructured":"Mekonnen GB, Addis SA. Factors affecting adherence to co-trimoxazole preventive therapy in HIV\/AIDS patients attending an antiretroviral therapy clinic in Ethiopia University Hospital: A cross-sectional study. Patients Prefer Adherence. 2020;14:881\u201390.","journal-title":"Patients Prefer Adherence"},{"key":"13067_CR41","unstructured":"FDRE M of S and T. National Research Ethics Review Guideline. 2014. pp. 1\u201395."},{"key":"13067_CR42","unstructured":"Ministry of Health. National Health Data Access and Sharing Guideline. Addis Ababa; 2021. pp. 1\u201349."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13067-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13067-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13067-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T23:52:56Z","timestamp":1777247576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13067-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13067"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13067-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involved the use of patients\u2019 medical records and databases. The research was conducted in compliance with the Declaration of Helsinki and all relevant national guidelines and regulations [\n                      \n                      ,\n                      \n                      ]. Ethical clearance was granted from the Institutional Review Board of Ambo University with reference number AUWC\/PG\/11\/16. The Ethics Committee of Ambo University, Woliso campus, waived the requirement for informed consent on behalf of patients\u2019 medical records and databases. Official support letters were obtained from the Zonal Health Office. Then, an official letter was submitted to the selected health facilities, and signed permission was obtained to access the ART clients\u2019 medical records and databases. Written consent was also obtained from the ART providers and data clerks. To maintain confidentiality, patient names and unique ART numbers were not included in the data extraction checklist, and data were not used for any purpose other than the stated study objectives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"831"}}